The estimated Net Worth of Stein Jacobsen is at least 19.3 百万$ dollars as of 23 November 2011. Stein Jacobsen owns over 9,195 units of Resmed stock worth over 13,188,008$ and over the last 15 years Stein sold RMD stock worth over 6,137,892$.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stein Jacobsen RMD stock SEC Form 4 insiders trading
Stein has made over 5 trades of the Resmed stock since 2009, according to the Form 4 filled with the SEC. Most recently Stein sold 9,195 units of RMD stock worth 232,450$ on 23 November 2011.
The largest trade Stein's ever made was selling 87,722 units of Resmed stock on 12 November 2010 worth over 2,915,002$. On average, Stein trades about 20,935 units every 93 days since 2009. As of 23 November 2011 Stein still owns at least 52,143 units of Resmed stock.
You can see the complete history of Stein Jacobsen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Stein Jacobsen's mailing address?
Stein's mailing address filed with the SEC is RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123.
Insiders trading at Resmed
Over the last 23 years, insiders at Resmed have traded over 250,830,262$ worth of Resmed stock and bought 10,000 units worth 424,500$ . The most active insiders traders include Peter C Farrell、Gary W Pace、David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of 3,005,701$. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth 246,420$.
What does Resmed do?
at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
What does Resmed's logo look like?
Complete history of Stein Jacobsen stock trades at Resmed
Resmed executives and stock owners
Resmed executives and other stock owners filed with the SEC include:
-
Michael Farrell,
Chief Executive Officer, Director -
Robert Douglas,
President, Chief Operating Officer -
Jim Hollingshead,
President – sleep and respiratory care business -
Rajwant Sodhi,
President – Software as a Service Business (SaaS) -
Brett Sandercock,
Chief Financial Officer -
Michael J. Farrell BE, SM, MBA,
CEO & Director -
David Pendarvis,
Chief Administrative Officer, Global General Counsel, Secretary -
Michael J. Farrell BE, MBA, SM,
CEO & Director -
Robert A. Douglas,
Pres & COO -
Dr. James R. Hollingshead Ph.D.,
Pres of Sleep & Respiratory Care Bus. -
Brett A. Sandercock,
Chief Financial Officer -
Peter Farrell,
Non-Executive Chairman of the Board -
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD,
Founder & Non-Exec. Chairman -
Dr. Peter C. Farrell A.M., B.E., Ph.D., BE (Hons), ScD, AM,
Founder & Non-Exec. Chairman -
Ronald Taylor,
Lead Independent Director -
Carol Burt,
Independent Director -
Richard Sulpizio,
Independent Director -
Harjit Gill,
Independent Director -
Jan De Witte,
Independent Director -
Karen Drexler,
Independent Director -
Justin Leong,
President – Asia and Latin America -
Urvashi Tyagi,
Chief Technology Officer -
Nupur Bhushan,
Chief People Officer -
David B. Pendarvis,
Chief Admin. Officer, Global Gen. Counsel & Corp. Sec. -
Amy Wakeham,
VP of Investor Relations & Corp. Communications -
Constance C. Bienfait,
Director of Investor Relations -
Kaushik Ghoshal,
Pres of SaaS Bus. & CTO -
John P Wareham,
Director -
Christopher G Roberts,
Director -
Donald Darkin,
Sr. Vice President, Pat Inter -
Gary W Pace,
Director -
Anne Reiser,
President - ResMed Europe -
Richard Mc Hale,
President, RC Business -
Inc Resmed,
Director -
James Hollingshead,
President, Sleep Business -
Kieran Gallahue,
President, Global -
Paul Eisen,
Vice President, Europe & Asia -
Donagh Mccarthy,
Director -
Adrian M Smith,
CFO -
Klaus H Shindhelm,
Sr. Vice President, Operations -
Keith Serzen,
Chief Operating Officer -
Louis A Simpson,
Director -
Christopher Bartlett,
Director -
Walter Flicker,
VP and Asst. Corp. Secretary -
Lasse Beijer,
COO-Europe -
Stein Jacobsen,
COO, Europe -
Michael A Quinn,
Director -
Kaushik Ghoshal,
President, SaaS Business -
Lucile Blaise,
President, Sleep & RC Business -
John Hernandez,
Director -
Desney Tan,
Director -
Michael J Rider,
Global General Counsel -
Christopher Del Orefice,
Director